IC

Ismail Ceylan

Président et CEO

Advanced BioDesign

Lyon, Auvergne-Rhone-Alpes


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Advanced BioDesign
Industry
biotechnology
Employees
20.0
Seniority
C suite
Total Funding
9771350.0
Latest Funding
Venture (Round not Specified)

Technologies

Outlook WordPress.org YouTube Wordpress.com Mobile Friendly Nginx Quantcast AI

Keywords

oncology aldh1 cancer treatment tumor resistance biopharmaceutical clinical trial acute myeloid leukemia aml pipeline development small molecule inhibitors predictive tests aldescreen monotherapy safety profile patient stratification chemoresistance drug development therapeutic innovation oncology solutions phase ii trial biotech company patient care cancer metabolism treatment efficacy molecular diagnostics cellular diagnostics preclinical studies cancer stem cells endogenous cell death apoptosis ferroptosis oxidative stress reactive aldehydes aldh inhibitors toxicity prevention immune modulation chemical compounds drug candidates research & development investor relations pharmaceutical partnerships healthcare solutions biotech investments health equity therapeutic targets treatment protocols patient outcomes genotoxic effects hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans